Not Signed In -
Cetuximab |
Erbitux |
Image:Cetuximab.png Cetuximab Systematic (IUPAC) name Humanized anti-EGF receptor (EGFr) antibody Identifiers CAS number 205923-56-4 ATC code ? PubChem ? DrugBank BTD00071 Chemical data Formula C6484H10042N1732O2023S36 Mol. weight 145781.6 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life 114 hrs Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Routes ? Cetuximab (Erbitu ...
Wikipedia - [full article]
Cetuximab Clinical Trials
- Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.
ClinicalTrials.gov Identifier: NCT00439517 - Recruiting
Metastatic Colorectal Cancer
- Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy
ClinicalTrials.gov Identifier: NCT00448097 - Recruiting
Prostatic Neoplasms
- A Study of Cetuximab in Patients who have Stage IV Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00055419 - Active, not recruiting
Colorectal Neoplasms
- Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00286130 - Active, not recruiting
Metastatic Colorectal Cancer
- Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients with Advanced/Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00112294 - Active, not recruiting
Non-Small-Cell Lung Carcinoma
- Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.
ClinicalTrials.gov Identifier: NCT00254137 - Active, not recruiting
Metastatic Colorectal Cancer
- Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00226239 - Active, not recruiting
Cancer
- Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00541112 - Recruiting
Colorectal Cancer
- Phase III Study of Irinotecan and Cetuximab vs Irinotecan as Second-Line Treatment in Patients with Metastatic, EGFR-Positive Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00063141 - Active, not recruiting
Colorectal Cancer
- Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
ClinicalTrials.gov Identifier: NCT00004865 - Active, not recruiting
Nose Cancer; Oral Cancer; Throat Cancer
- Cetuximab Combined with Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
ClinicalTrials.gov Identifier: NCT00154102 - Active, not recruiting
EGFR-expressing metastatic colorectal cancer
- CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00330746 - Active, not recruiting
Advanced Non-Small Cell Lung Cancer
- Phase III Study of Cetuximab, Oxaliplatin, 5-FU/LV vs. Oxaliplatin, 5-FU/LV in Patients with Previously Treated Metastatic, EGFR-Positive Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00061815 - Active, not recruiting
Colorectal Cancer
- Study of Erbitux (cetuximab) Given Alone to Patients with EGFR-undetectable Metastatic Colon or Rectal Cancer that is Refractory to Chemotherapy
ClinicalTrials.gov Identifier: NCT00083720 - Recruiting
Colorectal Neoplasms; Metastases; Neoplasm
- Oxaliplatin and Cetuximab in First-Line Treatment of mCRC
ClinicalTrials.gov Identifier: NCT00125034 - Active, not recruiting
first-line MCRC; EGFR positive; metastatic CRC
- Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00479752 - Not yet recruiting
Colorectal Cancer
- Study of Erbitux™ (Cetuximab) in Pediatric Patients with Refractory Solid Tumors
ClinicalTrials.gov Identifier: NCT00110357 - Recruiting
Cancer; Refractory solid tumor
- Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00203931 - Recruiting
Non-Small Cell Lung Cancer
- Docetaxel with Either Cetuximab Or Bortezomib As First-Line Therapy in Treating Patients with Stage III Or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00118183 - Active, not recruiting
Non-small cell lung cancer
- Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00020917 - Active, not recruiting
Stage IV rectal cancer; stage IV colon cancer
- Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
ClinicalTrials.gov Identifier: NCT00004227 - Active, not recruiting
Oral Cancer; Throat Cancer
- Cetuximab in Treating Patients With Metastatic Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00096031 - Active, not recruiting
Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage IV esophageal cancer
- Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
ClinicalTrials.gov Identifier: NCT00101192 - Recruiting
Cervical Cancer
- Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00086892 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Irinotecan and Cetuximab in Treating Patients With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00275041 - Active, not recruiting
Recurrent Breast Cancer; Stage IV Breast Cancer; Male Breast Cancer
- Radiation plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov Identifier: NCT00115518 - Recruiting
Carcinoma, Non-Small-Cell Lung
- Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00551759 - Not yet recruiting
Esophageal Cancer; Gastric Cancer
- Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases(CELIM)
ClinicalTrials.gov Identifier: NCT00153998 - Recruiting
Colorectal cancer, liver metastases
- Radiotherapy with Cisplatin Versus Radiotherapy with Cetuximab After Induction Chemotherapy for Larynx Preservation
ClinicalTrials.gov Identifier: NCT00169247 - Recruiting
Larynx Cancer; Hypopharynx Cancer
- Cetuximab and Carbo for ER/PR/HER2 Negative BC
ClinicalTrials.gov Identifier: NCT00420329 - Active, not recruiting
Breast Cancer
- Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
ClinicalTrials.gov Identifier: NCT00084318 - Active, not recruiting
Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
- Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00042939 - Active, not recruiting
adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer.
ClinicalTrials.gov Identifier: NCT00531115 - Not yet recruiting
Metastatic Colorectal Cancer
- Cetuximab, Combination Chemotherapy, and Radiation therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00109850 - Active, not recruiting
Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage III esophageal cancer
- Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas
ClinicalTrials.gov Identifier: NCT00075686 - Active, not recruiting
adenocarcinoma of the pancreas; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases from Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00056030 - Active, not recruiting
liver metastases; stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
- Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced or Regional Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00096174 - Active, not recruiting
stage IV squamous cell carcinoma of the hypopharynx; stage IV squamous cell carcinoma of the larynx; ...
- Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer
ClinicalTrials.gov Identifier: NCT00506844 - Active, not recruiting
Rectal Neoplasms; Neoadjuvant Treatment
- XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00215722 - Active, not recruiting
Colorectal Carcinoma
- Cetuximab in Patients with Unresectable or Metastatic Hepatocellular Carcinoma
ClinicalTrials.gov Identifier: NCT00142428 - Active, not recruiting
Unresectable hepatocellular carcinoma; Metastatic hepatocellular carcinoma; Hepatocellular Carcinoma
- Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer
ClinicalTrials.gov Identifier: NCT00315185 - Active, not recruiting
Carcinoma, Non-Small-Cell Lung
- Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
ClinicalTrials.gov Identifier: NCT00104910 - Recruiting
Cervical Cancer
- Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer
ClinicalTrials.gov Identifier: NCT00084773 - Active, not recruiting
recurrent rectal cancer; stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum
- Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00089297 - Active, not recruiting
Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
- Combination Chemotherapy, Bevacizumab, and Cetuximab in Treating Patients With Stage IV Colorectal Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00100841 - Active, not recruiting
adenocarcinoma of the colon; adenocarcinoma of the rectum; stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; ...
- A Study of 1018 ISS Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00403052 - Active, not recruiting
Colorectal Neoplasms
- Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer
ClinicalTrials.gov Identifier: NCT00362986 - Active, not recruiting
Dermatologic Complications; Unspecified Adult Solid Tumor, Protocol Specific
- Docetaxel or Pemetrexed with or without Cetuximab in Patients with Recurrent or Progressive Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00095199 - Recruiting
Non-Small-Cell Lung Cancer
- Cetuximab and Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00079066 - Active, not recruiting
Quality of Life; stage IV colon cancer; recurrent colon cancer; recurrent rectal cancer; Stage IV rectal cancer
- Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
ClinicalTrials.gov Identifier: NCT00079274 - Recruiting
stage III colon cancer; adenocarcinoma of the colon
- Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00571740 - Not yet recruiting
Colorectal Cancer
- Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum
ClinicalTrials.gov Identifier: NCT00077233 - Active, not recruiting
adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; recurrent rectal cancer; stage IV colon cancer; ...
- FLOX in Combination with Cetuximab in First-Line Treatment of Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00145314 - Recruiting
Metastatic Colorectal Cancer
- Cetuximab in Treating Patients With Stage IV Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00020930 - Active, not recruiting
recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
- Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer
ClinicalTrials.gov Identifier: NCT00130689 - Recruiting
Metastatic Esophageal and Gastric Cancer
- Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00134069 - Active, not recruiting
recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer
- Preoperative Chemoradiation With Capecitabine and Cetuximab
ClinicalTrials.gov Identifier: NCT00297128 - Recruiting
Rectal Cancer
- A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00251485 - Active, not recruiting
Colorectal Cancer
- Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00193453 - Active, not recruiting
Lung Cancer
- Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00227734 - Active, not recruiting
Colorectal Cancer
- Phase I/II Study of Cetuximab, Gemcitabine, and Carboplatin in Patients With Chemotherapy-Naive Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00027755 - Active, not recruiting
stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
- A Study of Mitomycin C, Irinotecan, and Cetuximab
ClinicalTrials.gov Identifier: NCT00271011 - Recruiting
Colorectal Cancer (CRC)
- Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00085501 - Active, not recruiting
recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; ...
- Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00081302 - Active, not recruiting
stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; ...
- Phase II Trial of Cetuximab in Patients with Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas
ClinicalTrials.gov Identifier: NCT00148109 - Recruiting
Unresectabale or metastatic high grade soft tissue or bony sarcoma
- Phase II - Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
ClinicalTrials.gov Identifier: NCT00321100 - Recruiting
Colorectal Neoplasms
- Phase I Cetuximab and Concurrent Radio-Chemotherapy
ClinicalTrials.gov Identifier: NCT00522886 - Recruiting
Non-Small Cell Lung Cancer
- Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00384878 - Recruiting
Stomach Neoplasms
- Retrospective Study Assessing Molecular Features Predicting Response to Cetuximab
ClinicalTrials.gov Identifier: NCT00491140 - Recruiting
Colorectal Neoplasms
- Vinflunine and Cetuximab as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00519831 - Active, not recruiting
Lung Cancer
- Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00251498 - Active, not recruiting
Carcinoma, Non-Small-Cell Lung
- Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00301028 - Active, not recruiting
Head and Neck Cancer
- FOLFIRI Plus Cetuximab Versus Bevacizumab in First Line Treatment CRC
ClinicalTrials.gov Identifier: NCT00433927 - Recruiting
Neoplasm Metastasis; Colorectal Cancer
- Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum
ClinicalTrials.gov Identifier: NCT00580073 - Recruiting
Rectal Cancer
- Cetuximab and Celecoxib in Treating Patients With Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00466505 - Active, not recruiting
Colorectal Cancer
- Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC
ClinicalTrials.gov Identifier: NCT00561054 - Recruiting
Carcinoma, Non-Small-Cell Lung
- Cetuximab With or Without Carboplatin in Treating Women With Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00232505 - Active, not recruiting
Breast Cancer
- BrUOG-EG-203 Cetuximab, Paclitaxel, Carboplatin and Radiation for Esophageal, Gastroesophageal Junction and Gastric Cancer
ClinicalTrials.gov Identifier: NCT00439608 - Active, not recruiting
Esophageal; Gastroesophageal; Gastric Cancer
- Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
ClinicalTrials.gov Identifier: NCT00251381 - Recruiting
Oropharyngeal Neoplasms
- Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, or Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00101348 - Recruiting
Gastrointestinal Cancer; Head and Neck Cancer; kidney and urinary cancer; thorax and respiratory cancer
- Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma
ClinicalTrials.gov Identifier: NCT00353717 - Recruiting
Breast Neoplasms
- Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00193219 - Recruiting
Colon Cancer
- Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00124618 - Recruiting
stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
- Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and GE Junction Carcinomas
ClinicalTrials.gov Identifier: NCT00319735 - Recruiting
Esophageal Cancer
- A Phase II Trial With Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas
ClinicalTrials.gov Identifier: NCT00463073 - Recruiting
Malignant Gliomas
- Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC
ClinicalTrials.gov Identifier: NCT00492206 - Recruiting
Non Small Cell Lung Cancer (NSCLC)
- Pre-op Rectal ChemoRad +/- Cetuximab
ClinicalTrials.gov Identifier: NCT00527111 - Recruiting
Rectal Cancer
- A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC
ClinicalTrials.gov Identifier: NCT00343291 - Recruiting
Non-Small Cell Lung Cancer; Malignant Pleural Effusions
- SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00361244 - Recruiting
Colorectal Carcinoma
- Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery
ClinicalTrials.gov Identifier: NCT00265811 - Recruiting
Colorectal Cancer
- Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract
ClinicalTrials.gov Identifier: NCT00524017 - Recruiting
Head and Neck Cancer; Precancerous/Nonmalignant Condition
- Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer
ClinicalTrials.gov Identifier: NCT00383695 - Recruiting
Colorectal Cancer
- Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer
ClinicalTrials.gov Identifier: NCT00477880 - Recruiting
Gastric Cancer; Precancerous/Nonmalignant Condition
- Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00091026 - Recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy
ClinicalTrials.gov Identifier: NCT00336856 - Recruiting
Colon Cancer; Rectum Cancer
- Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer
ClinicalTrials.gov Identifier: NCT00498992 - Recruiting
Dermatologic Complications; Unspecified Adult Solid Tumor, Protocol Specific
- Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00305760 - Recruiting
Pancreatic Cancer
- Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00368992 - Recruiting
Lung Cancer
- Cetuximab, Capecitabine and Oxaliplatin in Patients With EGFr Expressing Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00444678 - Recruiting
Colorectal Cancer; Neoplasm Metastasis
- Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
ClinicalTrials.gov Identifier: NCT00499369 - Recruiting
Colorectal Cancer
email this page
print this page
bookmark this page
feedback on this page
